Tylenol Autism, ADHD Lawsuits Continue to Be Filed After Reinstatement

Families suing Johnson & Johnson, Kenvue, and retailers over Tylenol use during pregnancy have regained their claims after a major appellate victory. The U.S. Court of Appeals for the Second Circuit reversed Judge Denise Cote's earlier decision to exclude the plaintiffs' key expert witnesses, finding that the judge had been too stringent in evaluating the reliability of their opinions linking prenatal acetaminophen exposure to autism and ADHD.

The litigation, consolidated as an MDL in the Southern District of New York, had stalled when Judge Cote granted a motion to exclude expert testimony and dismissed over 500 individual lawsuits before any reached a jury. Plaintiffs alleged that the defendants failed to warn pregnant women about research suggesting that acetaminophen use during pregnancy increases the risk of developmental disorders in children.

With the appellate reversal, the dismissed cases have been reinstated, and families now have another opportunity to pursue their claims. The reinstatement allows the litigation to move forward, with plaintiffs expected to continue filing additional lawsuits against the defendants.

This is a curated brief from the PlaintiffWire news desk. Read the original report at AboutLawsuits.